نتایج جستجو برای: alfa

تعداد نتایج: 18590  

Journal: :Archives of ophthalmology 2010
Mayumi Ueta Chie Sotozono Norihiko Yokoi Tsutomu Inatomi Shigeru Kinoshita

Maskin in 1994 as being effective in the treatment of ocular neoplasia. A limited number of cases in the literature also show the cytostatic effect of ATRA on ocular surface dysplasia. Our early experience with topical ATRA alone was consistent with early reports of effectiveness, with no response occurring in certain patients. Our early experience with topical interferon alfa-2b demonstrated a...

Journal: :Journal of the American College of Cardiology 2007
Piotr Ponikowski Stefan D Anker Joanna Szachniewicz Darlington Okonko Mark Ledwidge Robert Zymlinski Enda Ryan Scott M Wasserman Nigel Baker Dylan Rosser Stuart D Rosen Philip A Poole-Wilson Waldemar Banasiak Andrew J S Coats Ken McDonald

OBJECTIVES This study sought to investigate whether darbepoetin alfa, an erythropoiesis-stimulating protein (ESP), improves exercise capacity in patients with symptomatic chronic heart failure (CHF) and anemia. BACKGROUND Anemia is common in patients with CHF. METHODS In a multicenter, randomized, double-blind, placebo-controlled study, CHF patients with anemia (hemoglobin > or =9.0 to < or...

Journal: :Lancet 2014
Ira M Jacobson Gregory J Dore Graham R Foster Michael W Fried Monica Radu Vladimir V Rafalsky Larysa Moroz Antonio Craxi Monika Peeters Oliver Lenz Sivi Ouwerkerk-Mahadevan Guy De La Rosa Ronald Kalmeijer Jane Scott Rekha Sinha Maria Beumont-Mauviel

BACKGROUND Although the addition of the HCV NS3/4A protease inhibitors boceprevir and telaprevir to pegylated interferon (peginterferon) alfa plus ribavirin has improved sustained virological response (SVR) in treatment-naive and treatment-experienced patients infected with hepatitis C virus (HCV) genotype 1, the regimens have a high pill burden and are associated with increased rates and sever...

Journal: :Cancer 1998
B Orhan S Yalçin

BACKGROUND Anemia, one of the most common complications of cancer chemotherapy, has been managed with red blood cell (RBC) transfusions. As an alternative, the agent epoetin alfa has the potential to reduce the transfusion requirements of patients receiving cancer chemotherapy. To estimate the value that cancer patients place on the drug, an economic analysis using the concept of willingness to...

2014
Klaus Bühler Olaf GJ Naether Wilma Bilger

BACKGROUND Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) both have a role to play in follicular development during the natural menstrual cycle. LH supplementation during controlled ovarian stimulation (COS) for assisted reproductive technology (ART) is used for patients with hypogonadotropic hypogonadism. However, the use of exogenous LH in COS in normogonadotropic women under...

2011
Ayse Seyhan Baris Ata

Corifollitropin alfa is a synthetic recombinant follicle-stimulating hormone (rFSH) molecule containing a hybrid beta subunit, which provides a plasma half-life of ∼65 hours while maintaining its pharmocodynamic activity. A single injection of corifollitropin alfa can replace daily FSH injections for the first week of ovarian stimulation for in vitro fertilization. Stimulation can be continued ...

Journal: :Hepatology 2005
Naga Chalasani Cosme Manzarbeitia Peter Ferenci Wolfgang Vogel Robert J Fontana Michael Voigt Caroline Riely Paul Martin Lewis Teperman James Jiao Juan Carlos Lopez-Talavera

There is currently no effective treatment for recurrent hepatitis C after orthotopic liver transplantation (OLT). We therefore performed two randomized, controlled trials--a prophylaxis trial and a treatment trial--to evaluate the safety and efficacy of peginterferon alfa-2a in patients who had undergone OLT. The prophylaxis trial enrolled 54 patients within 3 weeks after OLT, and the treatment...

2012
Kartika Widayati Taroeno-Hariadi

Peginterferon-alfa 2a or alfa 2b plus ribavirin is the treatment of choice in chronic hepatitis C. Severe adverse effects may compromise efficacy of this regiment. There are few reports of warm autoimmune hemolytic anemia following interferon-alfa or peginterferon-alfa2b plus ribavirin treatment. This present report discusses autoimmune hemolytic anemia which developed during peginterferon alfa...

Journal: :hepatitis monthly 0
najmeh namazee infectious disease and tropical medicine research center, shahid beheshti university of sciences, ir iran shahnaz sali infectious disease and tropical medicine research center, shahid beheshti university of sciences, ir iran sorour asadi infectious disease and tropical medicine research center, shahid beheshti university of sciences, ir iran mostafa shafiei research center for gastroenterology and liver diseases, baqiatallah university of sciences, mollasadra st., vanak sq., p. o. box: 141553651, ir iran +98-2188067114, [email protected] bita behnava research center for gastroenterology and liver diseases, baqiatallah university of sciences, mollasadra st., vanak sq., p. o. box: 141553651, ir iran +98-2188067114, [email protected] seyed moayed alavian research center for gastroenterology and liver diseases, baqiatallah university of sciences, mollasadra st., vanak sq., p. o. box: 141553651, ir iran +98-2188067114, [email protected]; research center for gastroenterology and liver diseases, baqiatallah university of sciences, mollasadra st., vanak sq., p. o. box: 141553651, ir iran +98-2188067114, [email protected]

background despite significant advances in the treatment of chronic hepatitis c in the past decades, factors which can affect response rates to combination therapy; peginterferon and ribavirin, are still under study and reaching sustained virological response (svr) is affected by several different factors. objectives to investigate predictor factors contributing to svr in iranian patients. pati...

Journal: :iranian journal of blood and cancer 0
seyed-moayed alavian hassan abolghasemi seyyed mohammad miri maryam keshvari pegah karimi elizee bita behnava

background: hepatitis c virus (hcv) infection is the most common transfusion transmitted disease in poly-transfused patients worldwide. in this study we aimed to evaluate the effects of pegylated interferon alfa-2a (peg-ifn a-2a) in reducing serum alt and eradicating serum hepatitis c virus (hcv) rna in hcv infected polytransfused thalassemic patients. materials and methods: a cohort of 51 hcv-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید